FDA Safety Database Analysis Identifies Delayed Postmarketing Events for Eculizumab in NMOSD
A disproportionality analysis of the FAERS database evaluated 954 adverse event reports for eculizumab in neuromyelitis optica spectrum disorder, identifying ...

